In the latest trading session,, 3.4 million Lantern Pharma Inc (NASDAQ:LTRN) shares changed hands as the company’s beta touched 1.58. With the company’s most recent per share price at $4.12 changing hands around $0.09 or 2.23% at last look, the market valuation stands at $44.43M. LTRN’s current price is a discount, trading about -48.54% off its 52-week high of $6.12. The share price had its 52-week low at $2.55, which suggests the last value was 38.11% up since then. When we look at Lantern Pharma Inc’s average trading volume, we note the 10-day average is 0.26 million shares, with the 3-month average coming to 147.85K.
Analysts gave the Lantern Pharma Inc (LTRN) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 1 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended LTRN as a Hold, 1 felt it is a Buy and 0 rated the stock as Underweight.
Lantern Pharma Inc (NASDAQ:LTRN) trade information
Instantly LTRN is in green as seen in intraday trades today. With action 3.26%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -6.58%, with the 5-day performance at 3.26% in the green. However, in the 30-day time frame, Lantern Pharma Inc (NASDAQ:LTRN) is 34.20% up. Looking at the short shares, we see there were 0.26 million shares sold at short interest cover period of 5.2 days.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -37.87%. The 2025 estimates are for Lantern Pharma Inc earnings to increase by 4.66%, but the outlook for the next 5-year period is at -2.53% per year.
LTRN Dividends
Lantern Pharma Inc is expected to release its next quarterly earnings report on 2025-Jun-13.
Lantern Pharma Inc (NASDAQ:LTRN)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 14.10% of Lantern Pharma Inc shares while 21.12% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 24.59%. There are 21.12% institutions holding the Lantern Pharma Inc stock share, with VANGUARD GROUP INC the top institutional holder. As of 2024-06-30, the company held 3.3807% of the shares, roughly 0.36 million LTRN shares worth $1.7 million.
NEWEDGE ADVISORS, LLC holds the second largest percentage of outstanding shares, with 1.4604% or 0.16 million shares worth $0.73 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund . With 256.11 shares estimated at $1.08 million under it, the former controlled 2.37% of total outstanding shares. On the other hand, VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund held about 0.92% of the shares, roughly 99.27 shares worth around $0.42 million.
